Tuberculosis (TB), antimicrobial resistance (AMR) and non-communicable diseases (NCDs) have emerged as key areas of focus in the BRICS’ New Delhi Declaration, with member countries calling for greater investment in research, technology sharing, disease surveillance and preventive healthcare.



